10 results for «181»

Filter By

10 results

Advanced mitral TEER - LIVE case

24 Nov 2024 – From PCR London Valves 2024

Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:

  • A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...
Advanced mitral TEER - LIVE case

Imaging-guided left main PCI - LIVE case

17 May 2024 – From EuroPCR 2024

A 53-year-old male with a history of advanced malignancy (lung adenoma) and mid LAD PCI last year, along with multiple risk factors (hypertension, dyslipidemia, diabetes, and smoking), presented with angina and a positive stress test and CT. The angiography and CT showed significant left main stenosis...

Imaging-guided left main PCI

Transcatheter options for degenerated surgical aortic valves - LIVE case

08 Feb 2025 – From PCR Tokyo Valves 2025

A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.

A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...

Transcatheter options for degenerated surgical aortic valves - LIVE case

Transcatheter tricuspid valve replacement - LIVE case

15 May 2024 – From EuroPCR 2024

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Transcatheter tricuspid valve replacement

Transcatheter management of failed THV - LIVE case

09 Feb 2025 – From PCR Tokyo Valves 2025

An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

Transcatheter management of failed THV - LIVE case

How to treat emergency coronary perforation

17 Oct 2019

Complications

Perforations can be life threating complications, but if recognised quickly and managed correctly can have a positive outcome. This section explains how to treat a coronary perforation.
In total there are 5 types.

PCR Complication Team: Patrick Calvert, Eric Eeckhout, Michael Haude, Amir Lerman, Olivier Muller

Types of coronary perforation

There are five types...

Complications:coronary perforations

Challenging situations to access the aortic valve - Part 2

15 May 2024 – From EuroPCR 2024

This session features a series of selected EuroPCR 2024 Clinical Case submissions, showcasing various challenging scenarios encountered during transcatheter aortic valve interventions. Experts will present and discuss cases involving transbrachial TAVI, TAVI on a porcelain aorta, transcaval access, and other complex access approaches, providing valuable insights...

Challenging situations to access the aortic valve - Part 2

Comparison between OFR and QFR

06 Oct 2020

The aim of this study was to evaluate the diagnostic performance of OCT-based optical flow ratio (OFR) in unselected patients and compare it with angiography-based quantitative flow ratio (QFR), using wire-based FFR as reference standard.

Authors :

J. Huang, H. Emori, D. Ding, T. Kubo, W. Yu, P. Huang, S. Zhang, J. L. Gutiérrez-Chico, T. Akasaka, W. Wijns, S. Tu
EuroIntervention: Comparison between OFR and QFR

Left Atrial Appendage Closure after Ablation for Atrial Fibrillation - the OPTION Trial

17 Nov 2024

Alessandro Sticchi provides his take on the OPTION Trial presented at AHA 2024 in Chicago.

Alessandro Sticchi

Author

Alessandro Sticchi
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation - the OPTION Trial

Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)

08 Apr 2024

Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Author

Ali Nazmi Calik
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques
Didn’t find what you were looking for?